MAN
Mandrake Resources Limited
🇦🇺 ASX
⛏️ MINING
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
-6.67%
Annual Growth
5 years average annual capital growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
2
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Mandrake Resources Ltd. engages in the business of exploring and evaluating mineral resources. The company is headquartered in Perth, Western Australia. The Company’s segments include Utah Lithium Project, Jimperding Ni-Cu-PGE Project and Berinka Pine Creek Gold Project. The Utah Lithium Project is located in the Paradox Basin in south-eastern Utah and covers approximately 93,755 acres. The Utah Lithium Project also incorporates the Lisbon Valley uranium mining district. The Jimperding Project lies approximately 30 kilometers (km) east of Chalice Gold Mines Limited’s (Chalice) Julimar Ni-Cu-PGE discovery in the Jimperding Metamorphic Belt located 70 km northeast of Perth. Berinka Pine Creek Gold Project covers an approximately 289km2 exploration license in the under-explored western limb of the Pine Creek Orogen, Northern Territory, 180 km south of Darwin.
📈 Performance
Price History
-93.57%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.02
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in MAN
2
📊 Total Capital Earnings
$3K
🔃 Average investment frequency
26 weeks
💵 Average investment amount
$863
⏰ Last time a customer invested in MAN
106 days
MAN investor breakdown
💵 Income of investors
More than 200k
33%
150k - 200k
100k - 150k
50k - 100k
Less than 50k
33%
👶 Age of investors
18 - 25
26 - 34
50%
35 - 90
50%
🙋 Legal gender of investors
Female
Male
100%
Pearlers who invest in MAN also invest in...
BrainChip Holdings Ltd. engages in the development of software and hardware solutions for artificial intelligence and machine learning applications. The company is headquartered in Sydney, New South Wales and currently employs 63 full-time employees. The company went IPO on 2011-11-09. The Company’s software and hardware accelerated solutions for advanced AI and machine learning applications with a primary focus on the development of its Akida Neuromorphic Processor. The Company’s fully digital, event-based AI processor, Akida, uses neuromorphic principles to mimic the human brain, analyzing only essential sensor inputs at the point of acquisition, processing data with unparalleled efficiency, precision, and economy of energy. Akida enables Edge learning local to the chip, independent of the cloud, reducing latency while improving privacy and data security. Its other products include MetaTF, 2nd Generation akida, Akida1000 reference chip and Akida Enablement Platforms. Akida Enablement Platforms include Akida PCIe Board, Akida Development Kit Shuttle PC, and Akida Development Kit Raspberry Pi.
🙌 Performance (5Yr p.a)
72.16%
📊 Share price
$0.23 AUD
🤖 TECHNOLOGY
VTS.AX was created on 2009-05-12 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard U.S. Total Market Shares Index ETF seeks to track the performance of the CRSP US Total Market Index, providing investors with exposure to a broadly diversified collection of securities that, in the aggregate, approximates the full index in terms of key characteristics.
🙌 Performance (5Yr p.a)
20.85%
📊 Share price
$447.47 AUD
🤖 TECHNOLOGY
🇺🇸 UNITED STATES
⛳️ DIVERSIFIED
📈 HIGH PRICE GROWTH
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
16.74%
📊 Share price
$137.19 AUD
🌏 GLOBAL
⛳️ DIVERSIFIED
📈 HIGH PRICE GROWTH
🤖 TECHNOLOGY
A200.AX was created on 2018-05-07 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 7045.12m in AUM and 199 holdings. A200.AX aims to track the performance of an index (before fees and expenses) comprising 200 of the largest companies by market capitalisation listed on the ASX.
🙌 Performance (5Yr p.a)
10.99%
📊 Share price
$138.65 AUD
⛳️ DIVERSIFIED
💸 FINANCIALS
📈 HIGH PRICE GROWTH
🇦🇺 AUSTRALIA
VHY.AX was created on 2011-05-23 by Vanguard. The fund's investment portfolio concentrates primarily on high dividend yield equity. Vanguard Australian Shares High Yield ETF seeks to track the return of the FTSE Australia High Dividend Yield Index before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
12.29%
📊 Share price
$73.50 AUD
🧱 MATERIALS
💸 FINANCIALS
🇦🇺 AUSTRALIA
💰 HIGH DIVIDEND
📈 HIGH PRICE GROWTH
⛳️ DIVERSIFIED
Want more shares? Try these...
Microba Life Sciences Ltd. engages in the provision of microbiome testing, supplements and analysis services as well as developing new pathology services, therapeutics, and diagnostics based on the human gut microbiome. The company is headquartered in Brisbane, Queensland. The company went IPO on 2022-04-05. The firm is engaged in the discovery and development of therapeutics for major chronic diseases and delivering gut microbiome testing services globally to researchers, clinicians, and consumers. The company is engaged in providing microbiome testing, supplements and analysis services as well as developing new pathology services, therapeutics and diagnostics based on the human gut microbiome. The company offers various platforms, such as Analysis, Discovery, and Therapeutic. Its Analysis platform is an end-to-end solution for microbiome analysis. Using advanced metagenomic sequencing technology and proprietary bioinformatic tools, it provides precise and comprehensive measurement of the human gut microbiome. Its Discovery Platform is a global databank for microbiome discovery and develops new health solutions from the gut microbiome. Its Therapeutic platform is a repeatable platform for microbial therapeutic leads.
📊 Share price
$0.15 AUD
🩺 HEALTH CARE
Microequities Asset Management Group Ltd. engages in the provision of investment management services. The company is headquartered in Sydney, New South Wales. The company went IPO on 2018-04-30. The firm operates in the provision of fund management services with the objective of offering investment funds to wholesale and sophisticated investors. Its subsidiaries include Microequities Asset Management Pty Ltd, Microequities Venture Capital Pty Ltd, and Microequities Private Equity Asset Management Pty Ltd. Microequities Asset Management Pty Limited is the trustee of the Company.
🙌 Performance (5Yr p.a)
10.94%
📊 Share price
$0.49 AUD
💸 FINANCIALS
📈 HIGH PRICE GROWTH
💰 HIGH DIVIDEND